2229861-17-8 Usage
General Description
2-chloro-6-[3-(3,3,3-trifluoro-2,2-dimethyl-propoxy)pyrazol-1-yl]pyridine-3-carboxylic acid is a chemical compound with a complex structure. It contains a pyridine ring with a carboxylic acid group attached at the 3-position and a chloro group at the 2-position. Additionally, it features a pyrazole ring linked to the pyridine ring via a three-carbon bridge with a trifluoromethyl-substituted propoxy group attached to the pyrazole ring. This chemical compound may have various pharmacological or biological activities due to its unique structure, making it of interest for further research and potential applications in pharmaceuticals or other industries.
Check Digit Verification of cas no
The CAS Registry Mumber 2229861-17-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 2,2,2,9,8,6 and 1 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 2229861-17:
(9*2)+(8*2)+(7*2)+(6*9)+(5*8)+(4*6)+(3*1)+(2*1)+(1*7)=178
178 % 10 = 8
So 2229861-17-8 is a valid CAS Registry Number.
2229861-17-8Relevant articles and documents
PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
-
Paragraph 0590; 0601; 0604-0605, (2021/08/13)
The disclosure provides processes for preparing a compound of Formula (I).
PHARMACEUTICAL COMPOSITIONS FOR TREATING CYSTIC FIBROSIS
-
Paragraph 0560; 0561, (2019/08/20)
A pharmaceutical composition comprising Compound I: Methods of treating cystic fibrosis comprising administering one or more of such pharmaceutical compositions to a patient.
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
-
Paragraph 00175, (2019/10/29)
This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis using such modulators and pharmaceutical composi
